EQS-Ad-hoc: Fresenius Medical Care AG & Co. KGaA / Key word(s): Forecast modification
30-Oct-2022 / 17:30 CET/CEST
As Fresenius Medical Care continues to operate in a challenging environment, the impacts of the Company’s focused efforts to improve North American Healthcare Services operations are delayed from previous assumptions. Consequently, Fresenius Medical Care now assumes lower contributions for the 2022 financial year.
Consequently, Fresenius Medical Care now expects net profit (attributable to shareholders of Fresenius Medical Care AG & Co. KGaA) for the financial year 2022 to fall within the teen to mid-teen percentage range. around twenty. The Company continues to expect revenue growth in the single-digit percentage range in fiscal 2022. These targets are in constant currency and exclude special items.
Dr Dominik Heger
October 30, 2022 CET/CEST EQS distribution services include regulatory announcements, financial/corporate news and press releases.
|Company:||Fresenius Medical Care AG & Co. KGaA|
|61352 Bad Homburg|
|Call:||+49 (0) 6172- 609 2525|
|Fax:||+49 (0) 6172- 609 2301|
|Listed:||Regulated Market in Frankfurt (Prime Standard); Unofficial regulated market in Berlin, Düsseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange; NYSE, Luxembourg Stock Exchange|
|EQS News ID:||1475053|
|End of announcement||EQS News Service|
1475053 Oct 30, 2022 CET/CEST